Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate inhibition of mast cells and the histamine 1
receptor (H1R) for treatment of chronic prostatitis (CP) and chronic pelvic pain syndrome
(CPPS).
Phase:
Early Phase 1
Details
Lead Sponsor:
Northwestern University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)